Federal award
ABBOTT RAPID DX NORTH AMERICA LLC
SPE2DS21F0101
Contract
Obligated and Ceiling
- Obligated (net)
- $357,000,000.00
- Ceiling (potential value, not spending)
- $357,000,000.00
- Current value
- $357,000,000.00
- Gross positive obligations
- $357,000,000.00
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- ABBOTT RAPID DX NORTH AMERICA LLC · P782RNU1NNK3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- ABBOTT LABORATORIES · EF9EAJ1MF6U3
- Awarding agency
- Department of War · sub-agency 97AS · office SPE2DS
- Funding agency
- Department of War · sub-agency 97AS
- Product or service (PSC)
- 6640 · LABORATORY EQUIPMENT AND SUPPLIES
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- SPE2DS21F0101
- Parent vehicle (IDV PIID)
- SPE2DE21D0023
- Award type code
- C
- Actions
- 19 · Sep 2, 2021 to Jan 13, 2022
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History19
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Jan 13, 2022 | FY2022 | P00018 | D | $0.00 | — |
| Jan 8, 2022 | FY2022 | P00017 | D | $0.00 | — |
| Dec 30, 2021 | FY2022 | P00016 | D | $0.00 | — |
| Dec 25, 2021 | FY2022 | P00015 | D | $0.00 | — |
| Dec 19, 2021 | FY2022 | P00014 | D | $0.00 | — |
| Dec 13, 2021 | FY2022 | P00013 | D | $0.00 | — |
| Dec 7, 2021 | FY2022 | P00012 | D | $0.00 | — |
| Nov 29, 2021 | FY2022 | P00011 | D | $0.00 | — |
| Nov 19, 2021 | FY2022 | P00010 | D | $0.00 | — |
| Nov 15, 2021 | FY2022 | P00009 | D | $0.00 | — |
| Nov 8, 2021 | FY2022 | P00008 | D | $0.00 | — |
| Oct 31, 2021 | FY2022 | P00007 | D | $0.00 | — |
| Oct 25, 2021 | FY2022 | P00006 | D | $0.00 | — |
| Oct 15, 2021 | FY2022 | P00005 | D | $0.00 | — |
| Oct 12, 2021 | FY2022 | P00004 | D | $0.00 | — |
| Oct 1, 2021 | FY2022 | P00003 | D | $0.00 | — |
| Sep 23, 2021 | FY2021 | P00002 | D | $0.00 | — |
| Sep 16, 2021 | FY2021 | P00001 | D | $0.00 | — |
| Sep 2, 2021 | FY2021 | 0 | — | $357,000,000.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.